CV
CapsoVision, Inc. Common Stock
NASDAQ: CV · HEALTHCARE · MEDICAL DEVICES
$7.08
+10.62% today
Updated 2026-04-30
Market cap
$297.04M
P/E ratio
—
P/S ratio
21.92x
EPS (TTM)
$-1.03
Dividend yield
—
52W range
$3 – $15
Volume
0.3M
CapsoVision, Inc. Common Stock (CV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $9.75M | $11.76M | $13.55M |
| Revenue growth (YoY) | — | +20.5% | +15.3% |
| Cost of revenue | $4.26M | $5.38M | $6.38M |
| Gross profit | $5.49M | $6.38M | $7.17M |
| Gross margin | 56.3% | 54.2% | 52.9% |
| R&D | $9.33M | $15.12M | $18.31M |
| SG&A | $1.97M | $4.21M | $6.85M |
| Operating income | $-11.35M | $-19.92M | $225000.00 |
| Operating margin | -116.3% | -169.4% | 1.7% |
| EBITDA | $-10.96M | $-19.40M | $-24.95M |
| EBITDA margin | -112.4% | -165.0% | -184.1% |
| EBIT | $-11.35M | $-19.92M | $-25.52M |
| Interest expense | — | — | — |
| Income tax | $11000.00 | $11000.00 | — |
| Effective tax rate | -0.1% | -0.1% | 0.0% |
| Net income | $-11.30M | $-19.90M | $-25.32M |
| Net income growth (YoY) | — | -76.0% | -27.2% |
| Profit margin | -115.9% | -169.3% | -186.8% |